OTLK STOCK ALERT: Robbins LLP Reminds Investors of January 2, 2024, Lead Plaintiff Deadline in the Class Action Filed Against Outlook Therapeutics, Inc.
15 déc. 2023 19h03 HE
|
Robbins LLP
Outlook Therapeutics, Inc. (OTLK) Misled Investors About the Viability and Efficacy of its Lead Product Candidate
OTLK STOCK NEWS: Investors with Significant Losses in Outlook Therapeutics, Inc. Should Contact Robbins LLP for Information About the Outlook Therapeutics, Inc. Class Action
21 nov. 2023 16h52 HE
|
Robbins LLP
Outlook Therapeutics, Inc. (OTLK) Misled Investors About the Viability and Efficacy of its Lead Product Candidate
OTLK Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in the Outlook Therapeutics, Inc. Class Action
13 nov. 2023 18h08 HE
|
Robbins LLP
Outlook Therapeutics, Inc. (OTLK) Misled Investors About the Viability and Efficacy of its Lead Product Candidate
Shareholder Alert: Robbins LLP Informs Shareholders of Class Action Filed Against Outlook Therapeutics, Inc. (BCS)
07 nov. 2023 13h03 HE
|
Robbins LLP
Outlook Therapeutics, Inc. (OTLK) Misled Investors About the Viability and Efficacy of its Lead Product Candidate